Related Experiment Video
Updated: Jun 25, 2026

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
Published on: May 15, 2017
DAMPs ramp up drug toxicity
1Department of Medicine and Liver Center, UCSF, San Francisco, California, USA. jmaher@medsfgh.ucsf.edu
Abstract:
The clinical syndrome of acetaminophen-induced liver injury represents the combined result of drug toxicity and a potent innate immune response that follows drug-induced cell death. In this issue of the JCI, Imaeda and colleagues report that DNA released from dying hepatocytes is a key stimulus of innate immune activation in the acetaminophen-treated mouse liver (see the related article beginning on page 305). They present evidence indicating that hepatocyte DNA promotes immune activation by acting as a danger-associated molecular pattern (DAMP) that stimulates cytokine production in neighboring sinusoidal endothelial cells via Tlr9 and the Nalp3 inflammasome.
Insights
Acetaminophen overdose causes liver injury through drug toxicity and immune responses. Released hepatocyte DNA acts as a danger signal, activating immune cells and cytokine production in the liver.
Area of Science:
- Hepatology
- Immunology
- Toxicology
Background:
- Acetaminophen-induced liver injury (AILI) involves drug toxicity and innate immune responses.
- Drug-induced cell death triggers inflammation in the liver.
- Understanding immune activation mechanisms in AILI is crucial for developing treatments.
Discussion:
- Dying hepatocytes release DNA, acting as a danger-associated molecular pattern (DAMP).
- Hepatocyte DNA stimulates immune responses in liver sinusoidal endothelial cells.
- This activation involves Toll-like receptor 9 (Tlr9) and the Nalp3 inflammasome.
Key Insights:
- Hepatocyte DNA is a critical initiator of innate immune activation in acetaminophen-treated mouse livers.
- Tlr9 and Nalp3 inflammasome mediate DNA-induced cytokine production by endothelial cells.
- This study elucidates a key pathway in acetaminophen hepatotoxicity.
Outlook:
- Targeting DNA-mediated immune activation could offer novel therapeutic strategies for AILI.
- Further research may explore the role of extracellular DNA in other forms of liver injury.
- Investigating DAMPs provides insights into sterile inflammation in liver diseases.
Related Concept Videos
Drug Toxicity: Dose-Dependent Reactions
Desensitization and Tachyphylaxis
Several...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
